Skip to main content
Premium Trial:

Request an Annual Quote

Dominion Diagnostics Licenses Rights to LifeGen Genetic Test Technology

NEW YORK (GenomeWeb News) – Dominion Diagnostics today said that it has licensed rights to genetic testing technology from LifeGen.

The firms are currently collaborating on a study to validate LifeGen's test, which determines a patient's Genetic Addiction Risk Score. The test is being compared in the study to the Addiction Severity Index marketed by Inflexxion.

The LifeGen test includes a panel of genes primarily involved in brain reward circuitry, said North Kingston, RI-based Dominion Diagnostics. The firms, however, didn't provide specific details of which genes are in the panel, but they noted that a subset of the population "carries the DRD2 Type A1 receptor gene, which induces low dopamine brain function that results in the propensity for addictive cravings."

Further details of the alliance and licensing agreement were not disclosed.

The Scan

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.

Adenine Base Editor Targets SCID Mutation in New Study

Researchers from the University of California, Los Angeles, report in Cell that adenine base editing was able to produce functional T lymphocytes in a model of severe combined immune deficiency.

Researchers Find Gene Affecting Alkaline Sensitivity in Plants

Researchers from the Chinese Academy of Science have found a locus affecting alkaline-salinity sensitivity, which could aid in efforts to improve crop productivity, as they report in Science.

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.